<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">vavilov</journal-id><journal-title-group><journal-title xml:lang="ru">Вавиловский журнал генетики и селекции</journal-title><trans-title-group xml:lang="en"><trans-title>Vavilov Journal of Genetics and Breeding</trans-title></trans-title-group></journal-title-group><issn pub-type="epub">2500-3259</issn><publisher><publisher-name>Institute of Cytology and Genetics of Siberian Branch of the RAS</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18699/VJ15.063</article-id><article-id custom-type="elpub" pub-id-type="custom">vavilov-438</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>МОДЕЛИРОВАНИЕ ПАТОЛОГИЙ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>MODELING OF DISORDERS AND EXPERIMENTAL TREATMENT</subject></subj-group></article-categories><title-group><article-title>Корреляция чувствительности к гепатоканцерогенезу, индуцированному введением орто-аминоазотолуола, со степенью активации сигнальных путей Ahr и Car у мышей</article-title><trans-title-group xml:lang="en"><trans-title>Correlation of susceptibility to ortho-aminoazotolueneinduced hepatocarcinogenesis with Car and Ahr signaling pathway activation in mice</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Багинская</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Baginskaya</surname><given-names>N. V.</given-names></name></name-alternatives><email xlink:type="simple">bagin@bionet.nsc.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кашина</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kashina</surname><given-names>E. V.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шаманина</surname><given-names>М. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Shamanina</surname><given-names>M. Yu.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ильницкая</surname><given-names>С. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Ilnitskaya</surname><given-names>S. I.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Каледин</surname><given-names>В. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Kaledin</surname><given-names>V. I.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мордвинов</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Mordvinov</surname><given-names>V. A.</given-names></name></name-alternatives><email xlink:type="simple">mordvin@bionet.nsc.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">Федеральное государственное бюджетное научное учреждение «Федеральный исследовательский центр Институт цитологии и генетики Сибирского отделения Российской академии наук», Новосибирск, Россия<country>Россия</country></aff><aff xml:lang="en">Institute of Cytology and Genetics SB RAS, Novosibirsk, Russia<country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru">Федеральное государственное бюджетное научное учреждение «Федеральный исследовательский центр Институт цитологии и генетики Сибирского отделения Российской академии наук», Новосибирск, Россия&#13;
Федеральное государственное бюджетное научное учреждение «Научно-исследовательский институт молекулярной биологии и биофизики», Новосибирск, Россия<country>Россия</country></aff><aff xml:lang="en">Institute of Cytology and Genetics SB RAS, Novosibirsk, Russia&#13;
Institute of Molecular Biology and Biophysics, Novosibirsk, Russia<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2015</year></pub-date><pub-date pub-type="epub"><day>01</day><month>12</month><year>2015</year></pub-date><volume>19</volume><issue>4</issue><fpage>474</fpage><lpage>479</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Багинская Н.В., Кашина Е.В., Шаманина М.Ю., Ильницкая С.И., Каледин В.И., Мордвинов В.А., 2015</copyright-statement><copyright-year>2015</copyright-year><copyright-holder xml:lang="ru">Багинская Н.В., Кашина Е.В., Шаманина М.Ю., Ильницкая С.И., Каледин В.И., Мордвинов В.А.</copyright-holder><copyright-holder xml:lang="en">Baginskaya N.V., Kashina E.V., Shamanina M.Y., Ilnitskaya S.I., Kaledin V.I., Mordvinov V.A.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://vavilov.elpub.ru/jour/article/view/438">https://vavilov.elpub.ru/jour/article/view/438</self-uri><abstract><p>Орто-аминоазотолуол (ОАТ) является сильным гепатоканцерогеном для большинства линий мышей. Ранее было показано, что введение ОАТ активирует в печени этих животных арил-гидрокарбоновый рецептор (Ahr) и конститутивный рецептор андростанов (Car). Оба эти рецептора принимают непосредственное участие в процессе гепатоканцерогенеза. В данной работе были исследо- ваны влияние хронического введения ОАТ на уровни экспрессии мРНК Ahr, Car и их генов-мишеней Cyp1a1 и Cyp2b10, а также корреляция их экспрессии со степенью воспалительной реакции у линий мышей DD/He (DD) и CC57BR/Mv (BR), контрастных по чувствительности к гепатоканцерогенезу. Самцам мышей обеих линий в течение 2 мес. четырехкратно вводили масляный раствор ОАТ в дозе 225 мг/кг веса тела. Контрольные животные получали эквивалентное количество растворителя. Мышей забивали через 1 и 4 сут после последнего введения ОАТ. Экспрес­сию генов в печени определяли методом ПЦР в реальном вре­мени. Степень воспалительной реакции оценивали в те же сроки по концентрации фактора некроза опухоли альфа (ФНОα) в сыво­ротке крови. У резистентных мышей BR введение ОАТ инду­ци­ровало более выраженное и длительное повышение уров­ня экспрессии мРНК Cyp1a1, свидетельствующее о преимущест­венной активации Ahr у этих животных. В то же время у мышей чувствительной линии DD наблюдалось более выраженное повышение уровня экспрессии Cyp2b10, что указывает на преимущественную активацию Car. Также у мышей линии DD, в отличие от BR, наблюдалась сильная и длительная воспалительная реакция в ответ на введе­ние ОАТ. Полученные результаты дают основания полагать, что преобладание активации сигнального пути Ahr над активацией сигнального пути Car может быть фактором резистентности к ОАТ-индуцированному гепатоканцерогенезу.</p></abstract><trans-abstract xml:lang="en"><p>Ortho-aminoazotoluene (OAT) is a potent hepatocarcinogen for most strains of mice. It has previously been shown that OAT application activates the aryl hydrocarbon receptor (Ahr) and the constitutive androstane receptor (Car) in the mouse liver. Both of these receptors are directly involved in the process of hepatocarcinogenesis. In this study, we investigated the effect of chronic OAT administration on the mRNA expression levels of Ahr, Car and their target genes Cyp1a1 and Cyp2b10 in the liver of DD/He (DD) and CC57BR/Mv (BR) mouse strains contrasting in sensitivity to hepatocarcinogenesis. The inflammatory response of these strains was also studied. Male mice of both strains received OAT oil solution at the dose of 225 mg/kg body weight four times within two months. Control animals received the equivalent solvent amount. Mice were sacrificed on days 1 and 4 after the last OAT administration. Gene expression levels in the liver were determined by real-time PCR. The inflammatory response was evaluated by serum concentration of tumor necrosis factor alpha (TNF-alpha). In resistant BR mice, OAT induced a pronounced and prolonged increase in Cyp1a1 mRNA, showing primarily Ahr activation, while the DD strain displayed a more pronounced elevation of Cyp2b10 expression, indicative of Car activation. In addition, a strong inflammatory response to OAT was recorded in DD mice but not in BR. It is assumed that the prevalence of Ahr signaling pathway activation over Car signaling pathway activation is a factor of resistance to OAT-induced hepatocarcinogenesis.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>мыши</kwd><kwd>межлинейные различия</kwd><kwd>о-аминоазотолуол</kwd><kwd>Ahr</kwd><kwd>Car</kwd><kwd>ПЦР-РВ</kwd></kwd-group><kwd-group xml:lang="en"><kwd>mice</kwd><kwd>interlinear difference</kwd><kwd>o-aminoazotoluene</kwd><kwd>Ahr</kwd><kwd>Car</kwd><kwd>real-time PCR</kwd></kwd-group><funding-group xml:lang="ru"><funding-statement>Минобр­науки России, РФФИ</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Багинская Н.В., Ильницкая С.И., Никитенко Е.В., Каледин В.И. Промотирующее влияние орто-аминоазотолуола на гепатоканцерогенез сопровождается усилением воспалительных и пролиферативных процессов в ткани печени и снижением концентрации свободного тироксина в крови. Бюл. эксперим. биол. и мед. 2007;144(12):672-676.</mixed-citation><mixed-citation xml:lang="en">Baginskaya N.V., Il’nitskaya S.I., Nikitenko E.V., Kaledin V.I. Promoting Effect of o-Aminoazotoluene on Hepatocarcinogenesis is Accompanied by the Increase in Inflammatory and Proliferative Processes in Liver Tissue and Decrease in the Concentration of Free Thyroxin in the Blood. Byulleten eksperimentalnoj biologii i meditsini – Bulletin of Experimental Biology and Medicine. 2007;144(12):672-676.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Багинская Н.В., Перепечаева М.Л., Хощенко О.М., Душкин М.И. Влияние орто-аминоазотолуола на экспрессию генов PPAR-α, PPAR-γ, RXR-α и CAR в печени и уровень ИЛ-1β в крови у мышей контрастных по чувствительности к химическому гепатоканцерогенезу линий. Рецепция и внутриклеточная сигнализация. Пущино, 2009:1326-330.</mixed-citation><mixed-citation xml:lang="en">Baginskaya N.V., Perepechaeva M.L., Hochenko O.M., Dushkin M.I. The effect of o-aminoazotoluene on PPAR-α, PPAR-γ, RXR-α and CAR genes expression and serum level of IL-1β in mouse strains, contrasting in their susceptibility to chemical hepatocarcinogenesis. Mater. mezhdunar. conf. «Retseptsiya i vnutrikletochnaya signalizatsiya» [Abstr. of the International Conference «Reception and intercellular signaling»]. Pushchino, 2009;1:326-330.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Каледин В.И., Серова И.А., Семенова Л.А. Неодинаковая предрасположенность к развитию спонтанных и индуцированных опухолей печени у мышей разных линий и их гибридов. Эксперим. онкология. 1990;12(4):28-30.</mixed-citation><mixed-citation xml:lang="en">Beigneux A.P., Moser A.H., Shigenaga J.K., Grunfeld C., Feingold K.R. Reduction in cytochrome P-450 enzyme expression is associated with repression of CAR (constitutive androstane receptor) and PXR (pregnane X receptor) in mouse liver during the acute phase response. Biochem. Biophys Res. Commun. 2002;293:145-149.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Каледин В.И., Ильницкая С.И. Торможение метаболизма стимулирует, а активация метаболизма ингибирует канцерогенное действие орто-аминоазотолуола на печень мышей. Вопр. онкологии. 2011;57:216-220.</mixed-citation><mixed-citation xml:lang="en">Chen C.J., Chen D.S. Interaction of hepatitis B virus, chemical carcinogen, and genetic susceptibility: Multistage hepatocarcinogenesis with multifactorial etiology. Hepatology. 2002;36:1046-1049.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Тимофеева О.А., Филипенко М.Л., Рыкова Н.А., Гуляева Л.Ф., Ляхович В.В. Экспрессия CYP1A в печени мышей линий A/SN и CC57BR, различающихся по чувствительности к гепатоканцерогенному действию о-аминоазотолуола. Биохимия. 2000;65(6): 842-847.</mixed-citation><mixed-citation xml:lang="en">Cheung Y.L., Puddicombe S.M., Gray T.J., Ioannides C. Mutagenicity and CYP1A induction by azobenzenes correlates with their carcinogenicity. Carcinogenesis. 1994;15:1257-1263.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Beigneux A.P., Moser A.H., Shigenaga J.K., Grunfeld C., Feingold K.R. Reduction in cytochrome P-450 enzyme expression is associated with repression of CAR (constitutive androstane receptor) and PXR (pregnane X receptor) in mouse liver during the acute phase response. Biochem. Biophys Res. Commun. 2002;293:145-149.</mixed-citation><mixed-citation xml:lang="en">Fan Y., Boivin G.P., Knudsen E.S., Nebert D.W., Xia Y., Puga A. The aryl hydrocarbon receptor functions as a tumor suppressor of liver carcinogenesis. Cancer. Res. 2010;70:212-220.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Chen C.J., Chen D.S. Interaction of hepatitis B virus, chemical carcinogen, and genetic susceptibility: Multistage hepatocarcinogenesis with multifactorial etiology. Hepatology. 2002;36:1046-1049.</mixed-citation><mixed-citation xml:lang="en">Feo F., De Miglio M.R., Simile M.M., Muroni M.R., Calvisi D.F., Frau M., Pascale R.M. Hepatocellular carcinoma as a complex polygenic disease. Interpretive analysis of recent developments on genetic predisposition. Biochim. Biophys. Acta. 2006;1765:126-147.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Cheung Y.L., Puddicombe S.M., Gray T.J., Ioannides C. Mutagenicity and CYP1A induction by azobenzenes correlates with their carcinogenicity. Carcinogenesis. 1994;15:1257-1263.</mixed-citation><mixed-citation xml:lang="en">Gerbal-Chaloin S., Iankova I., Maurel P., Daujat-Chavanieu M. Nuclear receptors in the cross-talk of drug metabolism and inflammation. Drug Metab. Rev. 2013;45(1):122-144.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Fan Y., Boivin G.P., Knudsen E.S., Nebert D.W., Xia Y., Puga A. The aryl hydrocarbon receptor functions as a tumor suppressor of liver carcinogenesis. Cancer. Res. 2010;70:212-220.</mixed-citation><mixed-citation xml:lang="en">Glass C.K., Saijo K. Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells. Nat. Rev. Immunol. 2010;10:365-376. DOI: 10.1038/nri2748</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Feo F., De Miglio M.R., Simile M.M., Muroni M.R., Calvisi D.F., Frau M., Pascale R.M. Hepatocellular carcinoma as a complex polygenic disease. Interpretive analysis of recent developments on genetic predisposition. Biochim. Biophys. Acta. 2006;1765:126-147.</mixed-citation><mixed-citation xml:lang="en">Hanieh H. Toward understanding the role of aryl hydrocarbon receptor in the immune system: current progress and future trends. Biomed. Res. Int. 2014. DOI: 10.1155/2014/520763</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Gerbal-Chaloin S., Iankova I., Maurel P., Daujat-Chavanieu M. Nuclear receptors in the cross-talk of drug metabolism and inflammation. Drug Metab. Rev. 2013;45(1):122-144.</mixed-citation><mixed-citation xml:lang="en">Huang W., Zhang J., Washington M., Liu J., Parant J.M., Lozano G., Moore D.D. Xenobiotic stress induces hepatomegaly and liver tumors via the nuclear receptor constitutive androstane receptor. Mol. Endocrinol. 2005;19:1646-1653.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Glass C.K., Saijo K. Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells. Nat. Rev. Immunol. 2010;10:365-376. DOI: 10.1038/nri2748</mixed-citation><mixed-citation xml:lang="en">Kaledin V.I., Il’nitskaia S.I. Metabolism inhibition stimulates, metabolism activation inhibits cancerogenic activity of ortho-aminoazotoluene in mouse liver. Voprosy onkologii – Problems in onkology. 2011;57:216-220.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Hanieh H. Toward understanding the role of aryl hydrocarbon receptor in the immune system: current progress and future trends. Biomed. Res. Int. 2014. DOI: 10.1155/2014/520763</mixed-citation><mixed-citation xml:lang="en">Kaledin V.I., Serova I.A., Semenova L.A. Unequal predisposition to development of spontaneous and induced liver tumors in mice of different strains and their hybrids. Eksperim. onkologiya – Experimental Onkology. 1990;12(4):28-30.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Huang W., Zhang J., Washington M., Liu J., Parant J.M., Lozano G., Moore D.D. Xenobiotic stress induces hepatomegaly and liver tumors via the nuclear receptor constitutive androstane receptor. Mol. Endocrinol. 2005;19:1646-1653.</mixed-citation><mixed-citation xml:lang="en">Kolaya K.L., Stevenson D.E., Walborg Jr. E.F., Klaunig J.E. Cancer Biology: Dose dependence of phenobarbital promotion of preneoplastic hepatic lesions in F344 rats and B6C3F1 mice: effects on DNA synthesis and apoptosis. Carcinogenesis.  1995;17:947-954.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Kolaya K.L., Stevenson D.E., Walborg Jr. E.F., Klaunig J.E. Cancer Biology: Dose dependence of phenobarbital promotion of preneoplastic hepatic lesions in F344 rats and B6C3F1 mice: effects on DNA synthesis and apoptosis. Carcinogenesis. 1995;17:947-954.</mixed-citation><mixed-citation xml:lang="en">Liedtke C., Trautwein C. The role of TNF and Fas dependent signaling in animal models of inflammatory liver injury and liver cancer. Eur. J. Cell Biol. 2012;91(6/7):582-589. DOI: 10.1016/j.ejcb.2011.10.001</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Liedtke C., Trautwein C. The role of TNF and Fas dependent signaling in animal models of inflammatory liver injury and liver cancer. Eur. J. Cell Biol. 2012;91(6/7):582-589. DOI: 10.1016/j.ejcb.2011.10.001</mixed-citation><mixed-citation xml:lang="en">Marlowe J.L., Puga A. Aryl hydrocarbon receptor, cell cycle regulation, toxicity, and tumorigenesis. J. Cell Biochem. 2005;96:1174-1184.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Marlowe J.L., Puga A. Aryl hydrocarbon receptor, cell cycle regulation, toxicity, and tumorigenesis. J. Cell Biochem. 2005;96:1174-1184.</mixed-citation><mixed-citation xml:lang="en">Mikhailova O.N., Vasyunina E.A., Ovchinnikova L.P., Gulyaeva L.F., Timofeeva O.A., Filipenko M.L., Kaledin V.I. o-Aminoazotoluene does induce the enzymes of its own mutagenic activation in mouse liver. Toxicology. 2005;211:132-138.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Mikhailova O.N., Vasyunina E.A., Ovchinnikova L.P., Gulyaeva L.F., Timofeeva O.A., Filipenko M.L., Kaledin V.I. o-Aminoazotoluene does induce the enzymes of its own mutagenic activation in mouse liver. Toxicology. 2005;211:132-138.</mixed-citation><mixed-citation xml:lang="en">Miller E.C., Miller J.A. Searches for ultimate chemical carcinogens and their reactions with cellular macromolecules. Cancer. 1981;47(10): 2327-2345.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Miller E.C., Miller J.A. Searches for ultimate chemical carcinogens and their reactions with cellular macromolecules. Cancer. 1981;47(10): 2327-2345.</mixed-citation><mixed-citation xml:lang="en">Mitchell K.A., Lockhart C.A., Huang G., Elferink C.J. Sustained aryl hydrocarbon receptor activity attenuates liver regeneration. Mol. Pharmacol. 2006;70(1):163-170.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Mitchell K.A., Lockhart C.A., Huang G., Elferink C.J. Sustained aryl hydrocarbon receptor activity attenuates liver regeneration. Mol. Pharmacol. 2006;70(1):163-170.</mixed-citation><mixed-citation xml:lang="en">Moennikes O., Loeppen S., Buchmann A., Andersson P., Ittrich C., Poellinger L., Schwarz M.A. A constitutively active dioxin/aryl hydrocarbon receptor promotes hepatocarcinogenesis in mice. Cancer Res. 2004;64:4707-4710.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Moennikes O., Loeppen S., Buchmann A., Andersson P., Ittrich C., Poellinger L., Schwarz M.A. A constitutively active dioxin/aryl hydrocarbon receptor promotes hepatocarcinogenesis in mice. Cancer Res. 2004;64:4707-4710.</mixed-citation><mixed-citation xml:lang="en">Nakagawa H., Maeda S. Inflammation- and stress-related signaling pathways in hepatocarcinogenesis. World J. Gastroenterol. 2012; 18(31):4071-4081.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Nakagawa H., Maeda S. Inflammation- and stress-related signaling pathways in hepatocarcinogenesis. World J. Gastroenterol. 2012;18(31):4071-4081.</mixed-citation><mixed-citation xml:lang="en">Nebert D.W., Dalton T.P., Okey A.B., Gonzalez F.J. Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. J. Biol. Chem. 2004;279: 23847-23850.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Nebert D.W., Dalton T.P., Okey A.B., Gonzalez F.J. Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. J. Biol. Chem. 2004;279: 23847-23850.</mixed-citation><mixed-citation xml:lang="en">Patel R.D., Hollingshead B.D., Omiecinski C.J., Perdew G.H. Arylhydrocarbon receptor activation regulates constitutive androstane receptor levels in murine and human liver. Hepatology. 2007;46: 209-218.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Patel R.D., Hollingshead B.D., Omiecinski C.J., Perdew G.H. Arylhydrocarbon receptor activation regulates constitutive androstane receptor levels in murine and human liver. Hepatology. 2007;46: 209-218.</mixed-citation><mixed-citation xml:lang="en">Petrick J.S., Klaassen C.D. Importance of hepatic induction of constitutive androstane receptor and other transcription factors that regulate xenobiotic metabolism and transport. Drug Metab. Dispos. 2007;35(10):1806-1815.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Petrick J.S., Klaassen C.D. Importance of hepatic induction of constitutive androstane receptor and other transcription factors that regulate xenobiotic metabolism and transport. Drug Metab. Dispos. 2007;35(10):1806-1815.</mixed-citation><mixed-citation xml:lang="en">Smetanina M.A., Pakharukova M.Y., Kurinna S.M., Dong B., Hernandez J.P., Moore D.D., Merkulova T.I. Ortho-aminoazotoluene activates mouse constitutive androstane receptor (mCAR) and increases expression of mCAR target genes. Toxicol. Appl. Pharmacol. 2011;255:76-85.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Smetanina M.A., Pakharukova M.Y., Kurinna S.M., Dong B., Hernandez J.P., Moore D.D., Merkulova T.I. Ortho-aminoazotoluene activates mouse constitutive androstane receptor (mCAR) and increases expression of mCAR target genes. Toxicol. Appl. Pharmacol. 2011;255:76-85.</mixed-citation><mixed-citation xml:lang="en">Tian Y., Ke S., Denison M.S., Rabson A.B., Gallo M.A. Ah receptor and NF-kappaB interactions, a potential mechanism for dioxin toxicity. J. Biol. Chem. 1999;274:510-515.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Tian Y., Ke S., Denison M.S., Rabson A.B., Gallo M.A. Ah receptor and NF-kappaB interactions, a potential mechanism for dioxin toxicity. J. Biol. Chem. 1999;274:510-515.</mixed-citation><mixed-citation xml:lang="en">Timofeeva O.A., Filipenko M.L., Rychkova N.A., Gulyaeva L.F., Lyakhovich V.V. Expression of CYP1A in the mice of strains A/SN and CC57BR, differing in their sensitivity to a hepatocarcinogenic action of o-aminoazotoluene. Biokhimiya – Biochemistry (Moscow), 2000;65(6):718-722.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Vogel C.F., Matsumura F. A new cross-talk between the aryl hydrocarbon receptor and RelB, a member of the NF-kappaB family. Biochem. Pharmacol. 2009;77:734-745.</mixed-citation><mixed-citation xml:lang="en">Vogel C.F., Matsumura F. A new cross-talk between the aryl hydrocarbon receptor and RelB, a member of the NF-kappaB family. Biochem. Pharmacol. 2009;77:734-745.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Xie W., Yeuh M.F., Radominska-Pandya A., Saini S.P., Negishi Y., Bottroff B.S., Cabrera G.Y., Tukey R.H., Evans R.M. Control of steroid, heme, and carcinogen metabolism by nuclear pregnane X receptor and constitutive androstane receptor. Proc. Natl Acad. Sci. USA. 2003;100:4150-4155.</mixed-citation><mixed-citation xml:lang="en">Xie W., Yeuh M.F., Radominska-Pandya A., Saini S.P., Negishi Y., Bottroff B.S., Cabrera G.Y., Tukey R.H., Evans R.M. Control of steroid, heme, and carcinogen metabolism by nuclear pregnane X receptor and constitutive androstane receptor. Proc. Natl Acad. Sci. USA. 2003;100:4150-4155.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Yamamoto Y., Moore R., Goldsworthy T.L., Negishi M., Maronpot R.R. The orphan nuclear receptor constitutive active androstane receptor is essential for liver tumor promotion by phenobarbital in mice. Cancer Res. 2004;64(20):7197-7200.</mixed-citation><mixed-citation xml:lang="en">Yamamoto Y., Moore R., Goldsworthy T.L., Negishi M., Maronpot R.R. The orphan nuclear receptor constitutive active androstane receptor is essential for liver tumor promotion by phenobarbital in mice. Cancer Res. 2004;64(20):7197-7200.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Zacharova L.Yu., Gulyaeva L.F., Lyakhovich V.V., Mikhailova O.N., Timofeeva O.A., Filipenko M.L., Kaledin V.I. Cytochrome P4501A1 and 1A2 gene expression in the liver of 3-methylcholanthrene- and o-aminoazotoluene-treated mice: a comparison between PAH-responsive and PAH-nonresponsive strains. Toxicol. Sci. 2003;73: 108-113</mixed-citation><mixed-citation xml:lang="en">Zacharova L.Yu., Gulyaeva L.F., Lyakhovich V.V., Mikhailova O.N., Timofeeva O.A., Filipenko M.L., Kaledin V.I. Cytochrome P4501A1 and 1A2 gene expression in the liver of 3-methylcholanthrene- and o-aminoazotoluene-treated mice: a comparison between PAH-responsive and PAH-nonresponsive strains. Toxicol. Sci. 2003;73: 108-113.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
